NCT07549308Completed
Effect of a Protein Supplementation on Body Weight and Metabolic Variables in Overweight and Obese Patients
Source: ClinicalTrials.gov · Last updated 24 Apr 2026
Brief summary (registry, in English)
This study compares the effects of two calorie-restricted diets-one with whey protein supplementation and one without-and a health education control group on weight and metabolic parameters in overweight and obese individuals, with the aim of informing dietary intervention strategies for this population.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 110 (actual)
- First submitted
- 8 Aug 2024
- Start date
- 23 Feb 2024
- Primary completion date
- 17 Oct 2024
- Lead sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Diseases
- Obesity
- NCT number
- NCT07549308
What you commit to
- Study type: Interventional
- Participants enrolled: 110
- From 23 Feb 2024 to the primary completion date, 17 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Current use of medications that may affect weight or energy balance (e.g., lipid-lowering drugs, antidiabetic drugs, appetite suppressants), or other protein supplements
Other illness
- Gastrointestinal disorders that affect food digestion and absorption (e.g., chronic diarrhea, constipation, severe gastrointestinal inflammation, active peptic ulcer disease, post-gastrointestinal surgery)
- Psychiatric disorders
- Allergies to product ingredients or presence of inborn metabolic disorders
- Other conditions deemed unsuitable for participation in the study by the researchers (e.g., severe diseases not listed in the exclusion criteria)
Lab values
- Presence of acute or chronic viral hepatitis, abnormal liver function (ALT or/and AST \> 3 times the upper limit of normal), kidney disease (serum creatinine \> upper limit of normal), diabetes, malignant tumors, or cardiovascular diseases
Age
- Age \< 25 years or \> 35 years
Other
- Pregnancy or lactation
Who the study is looking for
- Age 25-35 years old, no gender restrictions
- Body mass index (BMI) ≥ 24 kg/m²
- Voluntary consent and signed informed consent form
Age in the registry: 25 years to 35 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital Zhejiang University School of Medicine Coordinator of this site? Confirm its status | Hangzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.